Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer

Patent filing and preclinical data for metastatic recurrence prevention in aggressive TNBC drive high score.